Inborn errors of pyrimidine degradation: Clinical, biochemical and molecular aspects

Journal of Inherited Metabolic Disease

Volumn 20, Issue 2, 1997, Pages 203-213

  Van Gennip, A H ^a   Abeling, N G G M ^a   Vreken, P ^a   Van Kuilenburg, A B P ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

3 AMINO 2 METHYLPROPIONIC ACID; 4 AMINOBUTYRIC ACID; AMINOTRANSFERASE; BETA ALANINE; NEUROTRANSMITTER; PYRIMIDINE; PYRIMIDINE DERIVATIVE; THYMINE; URACIL;

BIOCHEMISTRY; BODY FLUID; CANCER; CATABOLISM; CLINICAL FEATURE; CONFERENCE PAPER; DEGRADATION; ENZYME DEFECT; HUMAN; INBORN ERROR OF METABOLISM; MOLECULAR BIOLOGY; NEUROLOGIC DISEASE; PYRIMIDINE METABOLISM; SYMPTOMATOLOGY;

AMIDOHYDROLASES; ANIMALS; DIHYDROURACIL DEHYDROGENASE (NADP); HUMANS; OXIDOREDUCTASES; PURINE-PYRIMIDINE METABOLISM, INBORN ERRORS; PYRIMIDINES;

EID: 0031005437     PISSN: 01418955     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005356806329     Document Type: Conference Paper

References (46)

1. Adolph KJ, Fung E, McLeod DR, Morgan K, Snyder FF (1991) Dihydropyrimidine dehydrogenase deficiency in a Hutterite newborn. Adv Exp Med Biol 309B: 311-314.
2. Bakkeren JAJM, De Abreu RA, Sengers RCA, Gabreëls FJM, Maas JM, Renier WO (1984) Elevated urine, blood and cerebrospinal fluid levels of uracil and thymine in a child with dihydropyrimidine dehydrogenase deficiency. Clin Chim Acta 140: 247-256.
3. Berger R, Stoker-de Vries SA, Wadman SK, et al (1984) Dihydropyrimidine dehydrogenase deficiency leading to thymine-uraciluria. An inborn error of pyrimidine metabolism. Clin Chim Acta 141: 227-234.
4. Braakhekke JP, Renier WO, Gabriëls FJM, De Abreu RA, Bakkeren JAJ, Sengers RCA (1987) Dihydropyrimidine dehydrogenase deficiency. Neurological aspects. J Neurol Sci 78: 71-77.
5. Brockstedt M, Jakobs C, Smit LM, Van Gennip AH, Berger R (1990) A new case of dihydropyrimidine dehydrogenase deficiency. J Inher Metab Dis 13: 121-124.
6. Dagg CP, Coleman DL, Fraser M (1964) A gene effecting the rate of pyrimidine degradation in mice. Genetics 49: 979-989.
7. Diasio RB, Beavers TL, Carpenter JT (1988) Familial deficiency of dihydropyrimidine dehydrogenase. J Clin Invest 81: 47-51.
8. Diasio RB, Van Kuilenburg ABP, Lu Z, Zhang R, Van Lenthe H, Van Gennip AH (1994) Determination of dihydropyrimidine dehydrogenase (DPD) in fibroblasts of a DPD deficient pediatric patient and family members using a polyclonal antibody to human DPD. Adv Exp Med Biol 370: 7-10.
9. Duran M, Rovers P, De Bree PK, et al (1990) Dihydropyrimidinuria. Lancet 336: 817-818.
10. Duran M, Rovers P, De Bree PK, et al (1991) Dihydropyrimidinuria: a new inborn error of pyrimidine metabolism. J Inher Metab Dis 14: 367-370.
11. Gray RG, Pollitt J, Webley J (1987) Methylmalonic semialdehyde dehydrogenase deficiency: demonstration of defective valine and β-alanine metabolism and reduced malonic semialdehyde dehydrogenase activity in cultured fibroblasts. Biochem Med Metab Biol 38: 121-124.
12. Hamajima N, Matsuda K, Sakata S, Tamaki N, Sasaki M, Nonaka M (1996) A novel gene family defined by human dihydropyrimidinase and three related proteins with differential tissue distribution. Gene 180: 157-163..
13. Harris BE, Carpenter JT, Diasio RB (1991) Severe 5-fluorouracil toxicity secondary to dihydropyrimidine dehydrogenase deficiency: a potentially more common pharmacogenetic syndrome. Cancer 68: 499-501.
14. Harris H (1953) Family studies on the urinary excretion of β-aminoisobutyric acid. Ann Eugenics 18:43-49.
15. Henderson MJ, Ward K, Simmonds HA, Duley JA, Davies PM (1993) Dihydropyrimidinase deficiency presenting in infancy with severe developmental delay. J Inher Metab Dis 16: 574-576.
16. Higgins JJ, Kaneski CR, Bernardini I, Brady RO, Barton NW (1994) Pyridoxine-responsive hyper β-alaninemia with Cohen's syndrome. Neurology 44: 1728-1732.
17. Jakobs C, Stellaard F, Smit LME, et al (1991) The first prenatal diagnosis of dihydropyrimidine dehydrogenase deficiency. Eur J Pediatr 150: 291.
18. Jakobs C, Jaeken J, Gibson KM (1993) Inherited disorders of GABA metabolism. J Inher Metab Dis 16: 704-715.
19. Kakimoto Y, Taniguchi K, Sano I (1969) D-β-Aminoisobutyrate:pyruvate aminotransferase in mammalian liver and excretion of β-aminoisobutyrate in man. J Biol Chem 244: 335-340.
20. Lu Z, Zhang R, Diasio RB (1994) Dihydropyrimidine dehydrogenase activity in human peripheral blood mononuclear cells and liver: population characteristics, newly identified deficient patients, and clinical implication of 5-fluorouracil chemotherapy. Biochem Pharmacol 46: 945-952.
21. Meinsma R, Fernandez-Salguero P, Van Kuilenburg ABP, Van Gennip AH, Gonzalez FJ (1995) Human polymorphism in drug metabolism: mutation in the dihydropyrimidine dehydrogenase gene results in exon skipping and thymine-uraciluria. DNA Cell Biol 14: 1-6.
22. Ohba S, Kidouchi K, Sumi S, et al (1994) Dihydropyrimidinuria: the first case in Japan. Adv Exp Med Biol 370: 383-386.
23. Pollitt RJ, Green A, Smith R (1985) Excessive excretion of β-alanine and 3-hydroxypropionic, (R)-and (S)-3-aminoisobutyric, (R)- and (S)-3-hydroxyisobutyric and (S)-2-(hydroxymethyl)butyric acids probably due to a defect in the metabolism of the corresponding malonic semialdehydes. J Inher Metab Dis 8: 75-79.
24. Scriver CR, Gibson KM (1995) Disorders of β- and γ-amino acids in free and peptide-linked forms. In Scriver CR, Beaudet AL, Sly S, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease, 7th edn. New York: McGraw-Hill, vol I, part 5, 1349-1368.
25. Scriver CR, Pueschel S, Davies E (1966) Hyper-β-alaninemia associated with β-aminoaciduria and γ-aminoaciduria, somnolence and seizures. N Engl J Med 274: 635-643.
26. Taniguchi K, Tsujio T, Kakimoto Y (1972) Deficiency of β-aminoisobutyrate:pyruvate aminotransferase in the liver of genetic high excretors of D-β-aminoisobutyrate. Biochim Biophys Acta 279: 475-480.
27. Van Gennip AH (1987) Screening for inborn errors of purine and pyrimidine metabolism by bidimensional TLC and HPLC. In Zweig G, Sherma J, Krstulovic AM, eds. Handbook of Chromatography. Boca Raton, FL: CRC Press, vol. I, part A, 221-245.
28. Van Gennip AH, Van Bree-Blom EJ, Wadman SK, De Bree PK, Duran M, Beemer FA (1981a) Liquid chromatography of urinary pyrimidines for the evaluation of primary and secondary abnormalities of pyrimidine metabolism. In Hawk GL, Champlin PB, Hutton RF, Mol C, eds. Biological/Biomedical Applications of Liquid Chromatography III. New York and Basel: Marcel Dekker, Chromatographic Science Series 18, 285-296.
29. Van Gennip AH, Kamerling JP, De Bree PK, Wadman SK (1981b) Linear relationship between the R- and S-enantiomers of β-aminoisobutyric acid in human urine. Clin Chim Acta 116: 261-267.
30. Van Gennip AH, Bakker HD, Zoetekouw A, Abeling NGGM (1987a) A new case of thymineuraciluria. Klin Wochenschr 65 (suppl X): 14.
31. Van Gennip AH, Van Bree-Blom EJ, Abeling NGGM, Van Erven AJ, Voûte PA (1987b) β-Aminoisobutyric acid as a marker of thymine catabolism in malignancy. Clin Chim Acta 165: 365-377.
32. Van Gennip AH, Abeling NGGM, Elzinga-Zoetekouw L, Scholten EG, Van Cruchten A, Bakker HD (1989) Comparative study of thymine and uracil metabolism in healthy persons and in a patient with dihydropyrimidine dehydrogenase deficiency. Adv Exp Med Biol 253A: 111-118.
33. Van Gennip AH, Abeling NGGM, De Korte D (1990) Application of TLC and HPTLC for the detection of aberrant purine and pyrimidine metabolism in man. In Sherma J, Fried B, eds. Handbook of Thin-Layer Chromatography. New York: Marcel Dekker, Chromatographic Science Series 55, 863-906.
34. Van Gennip AH, Busch S, Elzinga L, et al (1993) Application of simple Chromatographic methods for the diagnosis of defects in pyrimidine degradation. Clin Chem 39: 380-385.
35. Van Gennip AH, Abeling NGGM, Stroomer AEM, Van Lenthe H, Bakker HD (1994) Clinical and biochemical findings in six patients with pyrimidine degradation defects. J Inher Metab Dis 17: 130-132.
36. Van Gennip AH, Van Lenthe H, Abeling NGGM, Bakker HD, Van Kuilenburg ABP (1995) Combined deficiencies of NADPH- and NADH-dependent dihydropyrimidine dehydrogenases, a new finding in a family with thymine-uraciluria. J Inher Metab Dis 189: 185-188.
37. Van Gennip AH, De Abreu RA, Van Lenthe H, Bakkeren J, Rotteveel J, Van Kuilenburg ABP (1996a) Dihydropyrimidinase deficiency: confirmation of the enzyme defect in dihydropyrimidinuria. J Inher Metab Dis 19 (supplement 1): abstract P18.
38. Van Gennip AH, Abeling NGGM, Vreken P, Van Kuilenburg ABP (1997) Genetic metabolic disease of pyrimidine metabolism: implications for diagnosis and treatment. Int Pediatr 12: 39-44.
39. Van Gennip AH, Van Lenthe H, Abeling NGGM, Scholten EG, Van Kuilenburg ABP (1996b) Inhibition of β-ureidopropionase by propionate may contribute to the neurologic complications in patients with propionic acidemia. J Inher Metab Dis 19 (supplement 1): abstract P86.
40. Van Kuilenburg ABP, Van Lenthe H, Van Gennip AH (1996a) Identification and tissue-specific expression of a NADH-dependent activity of dihydropyrimidine dehydrogenase in man. Anticancer Res 16: 389-394.
41. Van Kuilenburg ABP, Blom MJ, Van Lenthe H, Mul E, Van Gennip AH (1996b) The activity of dihydropyrimidine dehydrogenase in human blood cells. J Inher Metab Dis 19 (supplement 1): abstract P17.
42. Vreken P, Van Kuilenburg ABP, Meinsma R, et al (1996a) A point mutation in an invariant splice donor site leads to exon skipping in two unrelated Dutch patients with dihydropyrimidine dehydrogenase deficiency. J Inher Metab Dis 19: 645-654.
43. Vreken P, Van Kuilenburg ABP, Meinsma R, Van Gennip AH (1996b) Identification of novel point mutations in the dihydropyrimidine dehydrogenase gene. J Inher Metab Dis 19 (supplement 1): abstract P15.
44. Wadman SK, Beemer FA, De Bree PK, Duran M, Van Gennip AH, Ketting D, Van Sprang FJ (1984) New defects of pyrimidine metabolism. Adv Exp Med Biol 165: 109-114.
45. Wilcken B, Hammond J, Berger R, Wise G, James C (1985) Dihydropyrimidine dehydrogenase deficiency - a further case. J Inher Metab Dis 2: 115-116.
46. Yokota H, Fernandez-Salguero P, Furuiya H, et al (1994) c-DNA cloning and chromosome mapping of human dihydropyrimidine dehydrogenase, an enzyme associated with 5-fluorouracil toxicity and congenital thymine-uraciluria. J Biol Chem 269: 23192-23196.